Max Reinhardt, President at Pacira BioSciences, Inc. (PCRX), sold 25,000 shares at $63.51 ($1.6M) on 2020-11-13, disclosed to the SEC on 2020-11-17.
Open-market sale of $1.6M PCRX by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.67 | 4,000 | $251K | 15.8% |
| 2 | $63.51 | 21,000 | $1.3M | 84.2% |
| Total | $63.38 avg | 25,000 | $1.6M | 100% |
| Filing → |
| PCRX | SELL | 2023-06-07 | $83K | — | Filing → |
| PCRX | SELL | 2022-10-11 | $80K | — | Filing → |
| PCRX | SELL | 2022-06-08 | $497K | — | Filing → |